AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention Recipients

This award recognizes outstanding research accomplishments in cancer epidemiology, biomarkers, and prevention.

26th Annual Award Recipient
Meir J. Stampfer, MD
Associate Director
Brigham and Women's Hospital
Boston, Massachusetts

Dr. Stampfer delivered his award lecture titled “Decline in Prostate Cancer Rates – Bad News?” at the AACR Annual Meeting 2017 in Washington, D.C. The award presentation and lecture were held Tuesday, April 4, 2017, at the Washington Convention Center. 

The AACR and American Cancer Society established this award in 1992 to honor outstanding research accomplishments in cancer epidemiology and prevention. The 2017 AACR-ACS Award recipient embodies the traditions of scientific accomplishments represented by this award and its previous recipients.

Meir Stampfer, MD, DrPH, is honored for his outstanding contributions to the field of epidemiology, including the identification of a link between dietary factors and biomarkers to the risks of cancer.

Dr. Stampfer’s discovery that increased expression of insulin-like growth factor in the blood could predict elevated risk of prostate cancer is thought to have launched a major new field of epidemiologic investigation. Equally, his work that identified the utility of prostate-specific antigen for cancer screening, has transformed the field and is considered a landmark study in the prostate cancer field.

Dr. Stampfer has made seminal contributions in numerous areas within epidemiology, ranging from heart disease and stroke, diabetes, kidney stones, and cancer as well as methodologic contributions to cancer epidemiology has been a major focus for the past fifteen years. As a principal investigator for several NIH cancer grants, he has been continually funded for more than 20 years.

In recent years, Dr. Stampfer has focused on the lifestyle influeneces on lethal prostate cancer. He has also developed new biomarkers for prostate cancer prognosis, in blood and tumor tissue. Dr. Stampfer helped establish the hypothesis that lethal and the far more common indolent prostate cancer have different causes, and has provided insight into the effects of PSA screening on epidemiologic research in the area.

Dr. Stampfer earned his MD from New York University School of Medicine, and his MPH and DrPH from Harvard School of Public Health. He has received many honors and awards, including the mentorship award from the Prostate Cancer Foundation and an honorary doctoral degree from the University of Athens. He has consistently, over the past several decades, been among the five most highly cited scientists in clinical medicine.

Beyond Dr. Stampfer’s impressive research contributions, he is revered by colleagues as a superb leader and valued mentor to the next generation of cancer scientists. Many of his trainees have acquired leadership positions in epidemiology.

Award Recipients:

  • 2017: Meir J. Stampfer
  • 2016: Richard S. Peto
  • 2015: Mitchell H. Gail
  • 2014: Curtis C. Harris
  • 2013: Laurence N. Kolonel
  • 2012: Graham A. Colditz
  • 2011: John T. Schiller
  • 2010: Michael J. Thun
  • 2009: John D. Potter 
  • 2008: Robert N. Hoover 
  • 2007: Thomas W. Kensler 
  • 2006: Nicholas Edward Day
  • 2005: Ross L. Prentice
  • 2004: Malcolm C. Pike
  • 2003: Martin J. Blaser
  • 2002: Margaret R. Spitz
  • 2001: I. Bernard Weinstein
  • 2000: Walter C. Willett
  • 1999: Alice S. Whittemore
  • 1998: Ernst L. Wynder
  • 1997: Henry T. Lynch
  • 1996: Lee W. Wattenberg
  • 1995 - Frederick P. Li
  • 1994: Brian E. Henderson
  • 1993: Joseph F. Fraumeni Jr.
  • 1992: Pelayo Correa